Sign In

Henrik Sprengel

CEO at CanPharma

Dr. Henrik Sprengel is the Co-founder and CEO of CanPharma, a pharmaceutical company specializing in medical cannabis.1 He is a passionate entrepreneur and investor committed to making a change in the medical cannabis industry.2

As the leader of CanPharma, Dr. Sprengel is focused on bridging the gap between plant and patients, aiming to improve quality of life by delivering optimal cannabis-based treatment options.1 Under his leadership, CanPharma has positioned itself as a vertically integrated, data-driven pharmaceutical company covering the entire value chain of medical cannabis, including research and development, production, services for patients and doctors, and pharmaceutical distribution.1

Dr. Sprengel's vision for CanPharma includes:

  1. Establishing cannabis as a serious alternative to traditional pharmaceutical solutions
  2. Developing a holistic product portfolio based on proprietary genetics
  3. Using a data-driven approach to personalize treatments
  4. Focusing on education and knowledge transfer for doctors, pharmacists, and patients

With a background in entrepreneurship and investment, Dr. Sprengel has played a crucial role in rapidly expanding CanPharma's reach through strategic partnerships and assembling a seasoned management team.12

Highlights

Henrik Sprengel - Business News
Henrik Sprengel - Business News
Mar 18 · healtheuropa.com
CanPharma: bridging the gap between plant and patients
CanPharma: bridging the gap between plant and patients

Related Questions

What inspired Henrik Sprengel to co-found CanPharma?
How has CanPharma's approach to medical cannabis differed from other companies?
What are some of the key innovations CanPharma is working on?
How does CanPharma ensure the quality of its cannabis-based products?
What partnerships has CanPharma formed to advance its mission?
Henrik Sprengel
Henrik Sprengel, photo 1
Henrik Sprengel, photo 2
Add to my network

Location

Greater Barcelona Metropolitan Area